601
We report a case with chronic hepatitis C (CHC) who developed sarcoidosis after the treatment by interferon alpha and ribavirin.
 sarcoidosis: Effect; treatment by interferon alpha and ribavirin: Treatment; chronic hepatitis C (CHC): Treatment.Disorder; interferon alpha: Treatment.Drug; ribavirin: Treatment.Drug; interferon alpha: Combination.Drug; ribavirin: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 sarcoidosis: Effect; treatment by interferon alpha and ribavirin: Treatment; chronic hepatitis C (CHC): Treatment.Disorder; interferon alpha: Treatment.Drug; ribavirin: Treatment.Drug; interferon alpha: Combination.Drug; ribavirin: Combination.Drug